Annual EPS
$2.47
+$0.91+58.33%
31 December 2023
Summary:
Neurocrine Biosciences annual earnings per share is currently $2.47, with the most recent change of +$0.91 (+58.33%) on 31 December 2023. During the last 3 years, it has fallen by -$1.69 (-40.62%). NBIX annual EPS is now -40.63% below its all-time high of $4.16, reached on 31 December 2020.NBIX EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
$1.24
+$0.61+96.83%
30 September 2024
Summary:
Neurocrine Biosciences quarterly earnings per share is currently $1.24, with the most recent change of +$0.61 (+96.83%) on 30 September 2024. Over the past year, it has increased by +$0.42 (+51.22%). NBIX quarterly EPS is now -65.36% below its all-time high of $3.58, reached on 31 December 2020.NBIX Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
$3.73
+$0.42+12.69%
30 September 2024
Summary:
Neurocrine Biosciences TTM earnings per share is currently $3.73, with the most recent change of +$0.42 (+12.69%) on 30 September 2024. Over the past year, it has increased by +$1.87 (+100.54%). NBIX TTM EPS is now -18.38% below its all-time high of $4.57, reached on 30 September 2021.NBIX TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NBIX EPS Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +58.3% | +51.2% | +100.5% |
3 y3 years | -40.6% | +439.1% | -18.4% |
5 y5 years | +1022.7% | +121.4% | +2094.1% |
NBIX EPS High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -40.6% | +168.5% | -13.9% | +257.0% | -18.4% | +3290.9% |
5 y | 5 years | -40.6% | +1022.7% | -65.4% | +257.0% | -18.4% | +3290.9% |
alltime | all time | -40.6% | +145.3% | -65.4% | +136.9% | -18.4% | +168.4% |
Neurocrine Biosciences EPS History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $1.24(+96.8%) | $3.73(+12.7%) |
June 2024 | - | $0.63(+50.0%) | $3.31(-8.8%) |
Mar 2024 | - | $0.42(-70.8%) | $3.63(+50.0%) |
Dec 2023 | $2.47(+58.3%) | $1.44(+75.6%) | $2.42(+30.1%) |
Sept 2023 | - | $0.82(-13.7%) | $1.86(+7.5%) |
June 2023 | - | $0.95(-220.3%) | $1.73(+188.3%) |
Mar 2023 | - | -$0.79(-189.8%) | $0.60(-60.8%) |
Dec 2022 | $1.56(+69.6%) | $0.88(+27.5%) | $1.53(+168.4%) |
Sept 2022 | - | $0.69(-483.3%) | $0.57(+418.2%) |
June 2022 | - | -$0.18(-228.6%) | $0.11(-84.7%) |
Mar 2022 | - | $0.14(-275.0%) | $0.72(-20.9%) |
Dec 2021 | $0.92(-77.9%) | -$0.08(-134.8%) | $0.91(-80.1%) |
Sept 2021 | - | $0.23(-46.5%) | $4.57(+22.8%) |
June 2021 | - | $0.43(+30.3%) | $3.72(-9.3%) |
Mar 2021 | - | $0.33(-90.8%) | $4.10(-1.4%) |
Dec 2020 | $4.16(+966.7%) | $3.58(-677.4%) | $4.16(+347.3%) |
Sept 2020 | - | -$0.62(-176.5%) | $0.93(-55.9%) |
June 2020 | - | $0.81(+107.7%) | $2.11(+14.7%) |
Mar 2020 | - | $0.39(+11.4%) | $1.84(+457.6%) |
Dec 2019 | $0.39(+77.3%) | $0.35(-37.5%) | $0.33(+94.1%) |
Sept 2019 | - | $0.56(+3.7%) | $0.17(+30.8%) |
June 2019 | - | $0.54(-148.2%) | $0.13(-127.1%) |
Mar 2019 | - | -$1.12(-689.5%) | -$0.48(-382.4%) |
Dec 2018 | $0.22(-113.6%) | $0.19(-63.5%) | $0.17(+240.0%) |
Sept 2018 | - | $0.52(-842.9%) | $0.05(-108.3%) |
June 2018 | - | -$0.07(-85.1%) | -$0.60(-50.4%) |
Mar 2018 | - | -$0.47(-771.4%) | -$1.21(-26.2%) |
Dec 2017 | -$1.62(-0.6%) | $0.07(-153.8%) | -$1.64(-26.1%) |
Sept 2017 | - | -$0.13(-80.9%) | -$2.22(-11.9%) |
June 2017 | - | -$0.68(-24.4%) | -$2.52(+9.6%) |
Mar 2017 | - | -$0.90(+76.5%) | -$2.30(+42.0%) |
Dec 2016 | -$1.63(+55.2%) | -$0.51(+18.6%) | -$1.62(+11.7%) |
Sept 2016 | - | -$0.43(-6.5%) | -$1.45(+2.1%) |
June 2016 | - | -$0.46(+109.1%) | -$1.42(+14.5%) |
Mar 2016 | - | -$0.22(-35.3%) | -$1.24(+20.4%) |
Dec 2015 | -$1.05(+29.6%) | -$0.34(-15.0%) | -$1.03(+8.4%) |
Sept 2015 | - | -$0.40(+42.9%) | -$0.95(+25.0%) |
June 2015 | - | -$0.28(+2700.0%) | -$0.76(+15.2%) |
Mar 2015 | - | -$0.01(-96.2%) | -$0.66(-19.5%) |
Dec 2014 | -$0.81(+17.4%) | -$0.26(+23.8%) | -$0.82(+13.9%) |
Sept 2014 | - | -$0.21(+16.7%) | -$0.72(+5.9%) |
June 2014 | - | -$0.18(+5.9%) | -$0.68(0.0%) |
Mar 2014 | - | -$0.17(+6.3%) | -$0.68(-1.4%) |
Dec 2013 | -$0.69(-962.5%) | -$0.16(-5.9%) | -$0.69(+76.9%) |
Sept 2013 | - | -$0.17(-5.6%) | -$0.39(+44.4%) |
June 2013 | - | -$0.18(0.0%) | -$0.27(+170.0%) |
Mar 2013 | - | -$0.18(-228.6%) | -$0.10(-242.9%) |
Dec 2012 | $0.08(-88.1%) | $0.14(-380.0%) | $0.07(-240.0%) |
Sept 2012 | - | -$0.05(+400.0%) | -$0.05(-108.9%) |
June 2012 | - | -$0.01(0.0%) | $0.56(-8.2%) |
Mar 2012 | - | -$0.01(-150.0%) | $0.61(-9.0%) |
Dec 2011 | $0.67(-546.7%) | $0.02(-96.4%) | $0.67(-4.3%) |
Sept 2011 | - | $0.56(+1300.0%) | $0.70(+250.0%) |
June 2011 | - | $0.04(-20.0%) | $0.20(+185.7%) |
Mar 2011 | - | $0.05(0.0%) | $0.07(-141.2%) |
Dec 2010 | -$0.15 | $0.05(-16.7%) | -$0.17(-58.5%) |
Sept 2010 | - | $0.06(-166.7%) | -$0.41(-39.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2010 | - | -$0.09(-52.6%) | -$0.68(-30.6%) |
Mar 2010 | - | -$0.19(0.0%) | -$0.98(-24.6%) |
Dec 2009 | -$1.30(-43.5%) | -$0.19(-9.5%) | -$1.30(-29.7%) |
Sept 2009 | - | -$0.21(-46.2%) | -$1.85(-11.9%) |
June 2009 | - | -$0.39(-23.5%) | -$2.10(-7.1%) |
Mar 2009 | - | -$0.51(-31.1%) | -$2.26(-1.7%) |
Dec 2008 | -$2.30(-57.8%) | -$0.74(+60.9%) | -$2.30(-53.3%) |
Sept 2008 | - | -$0.46(-16.4%) | -$4.92(-5.0%) |
June 2008 | - | -$0.55(0.0%) | -$5.18(-2.6%) |
Mar 2008 | - | -$0.55(-83.6%) | -$5.32(-2.4%) |
Dec 2007 | -$5.45(+91.9%) | -$3.36(+366.7%) | -$5.45(+120.6%) |
Sept 2007 | - | -$0.72(+4.3%) | -$2.47(-11.2%) |
June 2007 | - | -$0.69(+1.5%) | -$2.78(-1.4%) |
Mar 2007 | - | -$0.68(+78.9%) | -$2.82(-0.4%) |
Dec 2006 | -$2.84(+373.3%) | -$0.38(-63.1%) | -$2.83(-8.7%) |
Sept 2006 | - | -$1.03(+41.1%) | -$3.10(+123.0%) |
June 2006 | - | -$0.73(+5.8%) | -$1.39(+71.6%) |
Mar 2006 | - | -$0.69(+6.2%) | -$0.81(+28.6%) |
Dec 2005 | -$0.60(-52.4%) | -$0.65(-195.6%) | -$0.63(+15.7%) |
Sept 2005 | - | $0.68(-553.3%) | -$0.54(-57.3%) |
June 2005 | - | -$0.15(-70.6%) | -$1.27(-11.2%) |
Mar 2005 | - | -$0.51(-9.6%) | -$1.43(+12.6%) |
Dec 2004 | -$1.26(+35.5%) | -$0.56(+1028.6%) | -$1.27(+105.7%) |
Sept 2004 | - | -$0.05(-83.9%) | -$0.62(-29.6%) |
June 2004 | - | -$0.31(-11.4%) | -$0.88(-2.2%) |
Mar 2004 | - | -$0.35(-487.2%) | -$0.90(-8.2%) |
Dec 2003 | -$0.93(-70.0%) | $0.09(-129.2%) | -$0.98(-58.1%) |
Sept 2003 | - | -$0.31(-6.1%) | -$2.34(-13.0%) |
June 2003 | - | -$0.33(-23.3%) | -$2.69(-10.6%) |
Mar 2003 | - | -$0.43(-66.1%) | -$3.01(-2.9%) |
Dec 2002 | -$3.10(+118.3%) | -$1.27(+92.4%) | -$3.10(+30.3%) |
Sept 2002 | - | -$0.66(+1.5%) | -$2.38(+46.0%) |
June 2002 | - | -$0.65(+25.0%) | -$1.63(+8.7%) |
Mar 2002 | - | -$0.52(-5.5%) | -$1.50(+4.9%) |
Dec 2001 | -$1.42(+9.2%) | -$0.55(-711.1%) | -$1.43(+10.0%) |
Sept 2001 | - | $0.09(-117.3%) | -$1.30(-26.1%) |
June 2001 | - | -$0.52(+15.6%) | -$1.76(+18.9%) |
Mar 2001 | - | -$0.45(+7.1%) | -$1.48(+13.0%) |
Dec 2000 | -$1.30(+47.7%) | -$0.42(+13.5%) | -$1.31(+21.3%) |
Sept 2000 | - | -$0.37(+54.2%) | -$1.08(+14.9%) |
June 2000 | - | -$0.24(-14.3%) | -$0.94(0.0%) |
Mar 2000 | - | -$0.28(+47.4%) | -$0.94(+6.8%) |
Dec 1999 | -$0.88(-20.0%) | -$0.19(-17.4%) | -$0.88(-16.2%) |
Sept 1999 | - | -$0.23(-4.2%) | -$1.05(+1.0%) |
June 1999 | - | -$0.24(+9.1%) | -$1.04(-16.8%) |
Mar 1999 | - | -$0.22(-38.9%) | -$1.25(+13.6%) |
Dec 1998 | -$1.10(-492.9%) | -$0.36(+63.6%) | -$1.10(+48.6%) |
Sept 1998 | - | -$0.22(-51.1%) | -$0.74(+54.2%) |
June 1998 | - | -$0.45(+542.9%) | -$0.48(+2300.0%) |
Mar 1998 | - | -$0.07(<-9900.0%) | -$0.02(-107.1%) |
Dec 1997 | $0.28(-22.2%) | $0.00(-100.0%) | $0.28(-49.1%) |
Sept 1997 | - | $0.04(+300.0%) | $0.55(+12.2%) |
June 1997 | - | $0.01(-95.7%) | $0.49(-16.9%) |
Mar 1997 | - | $0.23(-14.8%) | $0.59(+63.9%) |
Dec 1996 | $0.36 | $0.27(-1450.0%) | $0.36(+300.0%) |
Sept 1996 | - | -$0.02(-118.2%) | $0.09(-18.2%) |
June 1996 | - | $0.11 | $0.11 |
FAQ
- What is Neurocrine Biosciences annual earnings per share?
- What is the all time high annual EPS for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual EPS year-on-year change?
- What is Neurocrine Biosciences quarterly earnings per share?
- What is the all time high quarterly EPS for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly EPS year-on-year change?
- What is Neurocrine Biosciences TTM earnings per share?
- What is the all time high TTM EPS for Neurocrine Biosciences?
- What is Neurocrine Biosciences TTM EPS year-on-year change?
What is Neurocrine Biosciences annual earnings per share?
The current annual EPS of NBIX is $2.47
What is the all time high annual EPS for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual earnings per share is $4.16
What is Neurocrine Biosciences annual EPS year-on-year change?
Over the past year, NBIX annual earnings per share has changed by +$0.91 (+58.33%)
What is Neurocrine Biosciences quarterly earnings per share?
The current quarterly EPS of NBIX is $1.24
What is the all time high quarterly EPS for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly earnings per share is $3.58
What is Neurocrine Biosciences quarterly EPS year-on-year change?
Over the past year, NBIX quarterly earnings per share has changed by +$0.42 (+51.22%)
What is Neurocrine Biosciences TTM earnings per share?
The current TTM EPS of NBIX is $3.73
What is the all time high TTM EPS for Neurocrine Biosciences?
Neurocrine Biosciences all-time high TTM earnings per share is $4.57
What is Neurocrine Biosciences TTM EPS year-on-year change?
Over the past year, NBIX TTM earnings per share has changed by +$1.87 (+100.54%)